Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.

AstraZeneca is globally withdrawing its COVID-19 vaccine, Covishield, due to a surplus of newer vaccines and declining demand. The company highlights the vaccine's significant role in combating the...

AstraZeneca has withdrawn its COVID-19 vaccine globally due to a surplus of updated vaccines. The company cites a decline in demand for Vaxzevria, which was sold as Covishield in India.

Bharat Biotech assures Covaxin is safe and effective, with no reported side effects like blood clots, unlike Covishield. Developed with safety as priority, it was rigorously tested.

Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.

BigBloc Construction's board has approved a 1:1 bonus share issue for shareholders, boosting share price and aiming to reward investors. The bonus issue is subject to shareholder approval at the...

Stallion India Fluorochemicals, a supplier of refrigerants, has received Sebi's approval to float an IPO. The IPO includes a fresh issue of shares and an offer-for-sale component.

SBI MD Ashwini Tewari advocates for a CRR cut to help banks facing low deposit growth, citing the need for resources to fund economic activity. He highlights the pressure on banks due to the gap...

India's Economic Survey highlights GST's role in reducing logistics costs, improving truck travel time, and boosting manufacturing. Learn about the impact on logistics performance and India's...

India's Economic Survey suggests removing food from the inflation-targeting framework, arguing that higher food prices are often supply-induced. It proposes using coupons or direct cash transfers...

BigBloc Construction's board has approved a 1:1 bonus share issue for shareholders, boosting share price and aiming to reward investors. The bonus issue is subject to shareholder approval at the...

Stallion India Fluorochemicals, a supplier of refrigerants, has received Sebi's approval to float an IPO. The IPO includes a fresh issue of shares and an offer-for-sale component.

India's R&D investment as a percentage of GDP remains low compared to China and the US, with private sector contribution also lagging, according to the Economic Survey 2023-24.

SBI MD Ashwini Tewari advocates for a CRR cut to help banks facing low deposit growth, citing the need for resources to fund economic activity. He highlights the pressure on banks due to the gap...

India's Economic Survey warns of risks from rising retail investor participation in the stock market, highlighting potential for overconfidence and speculation. Read more.